Saturday, May 31, 2025

Latest

Singapore-Based A SPAC II Acquisition Prices US$185 Million IPO

Special purpose acquisition company A SPAC II Acquisition Corp. (Nasdaq: ASCBU) started trading on the Nasdaq Capital Market on Tuesday. The firm aims to raise US$185.0 million in its initial public offering.

The offering consisted of 18.5 million company units at US$10.00 per unit. Each unit contains one Class A common share, one-half of a redeemable warrant, and one-tenth of a right. Each whole warrant is exercisable for one common share at US$11.50 per share while each whole right equates to one common share upon business combination. The shares, warrants, and rights, once trading separately, will be trading under “ASCB”, “ASCBW”, and “ASCBR”, respectively.

Maxim Group acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 2.8 million units at the same IPO price.

The Singapore-based blank check firm intends to focus on completing a business combination in Proptech and Fintech, with particular preference to companies employing ESG principles.

Its predecessor A SPAC I Acquisition Corp. (Nasdaq: ASCAU) launched its US$60-million initial public offering in February 2022.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

ESGold Begins Concentration Tests Ahead Of First Production

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

Related News

Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq...

Friday, July 9, 2021, 09:53:00 AM

Eye Care Firm Bausch + Lomb Seeks To Raise $630 Million In NYSE, TSX IPOs

Bausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO)...

Friday, May 6, 2022, 02:24:00 PM

Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq...

Tuesday, August 30, 2022, 02:19:00 PM

Ripple Plans For Public Debut Following SEC Lawsuit Settlement

Despite an ongoing SEC lawsuit, major cryptocurrency company Ripple has not given up on making...

Friday, April 30, 2021, 02:38:00 PM

Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the...

Tuesday, July 6, 2021, 11:20:00 AM